PATENT CLAIM ANALYSIS

Application Number: 15971936
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "171000"]

Abstract:
Pharmaceutical compositions, methods for treating various issues of the eyes, and methods of preparing such compositions are described. These pharmaceutical compositions may be for treating glaucoma, in preparation of eye surgery, during eye surgery, various post-op care (e.g., after cataract surgery, laser eye surgery, and the like), for treating dry eyes, and/or for promoting eyelash growth. These pharmaceutical compositions may comprise such active ingredients (APIs) as: timolol, latanoprost, brimonidine tartrate, dorzolamide, moxifloxacin HCl, dexamethasone PO4, phenylephrine HCl, lidocaine HCl, ketorolac tromethamine, bromfenac, prednisolone PO4, gatifloxacin, amniotic cytokine extract (ACE), prostaglandin E2 (PGE2), and combinations thereof.

Claim (Index 8):
The method according to  claim 3 , wherein the pharmaceutical composition is preservative free, aside from benzalkonium chloride (BAK).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.81944
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13184446', '15459529', '15066731', '13973825', '15329824']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.802133661470201
- 35 USC 102 Novelty (BERT): 0.5127339752437812
- Combined Prediction Score: 0.773193692847559
- Mean Citation Score: 256.626194
- Max Citation Score: 294.45096
- Similarity Product: 216.8363921582794

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test